{
    "name": "Abbott Laboratories",
    "logo": "Abbott Laboratories 2025 logo.svg",
    "type": "[[Public company|Public]]",
    "traded_as": "{{ubl|NYSE|ABT|[[S&P 100]] component|[[S&P 500]] component}} {{NYSE|ABT}}",
    "industry": "{{ubl|[[Healthcare industry|Health care]]|[[Medical devices]]|[[Pharmaceutical industry|Pharmaceutical]]}}",
    "founded": "{{Start date and age|df|=|yes|1888}} (as Abbott Alkaloidal Company) in [[Ravenswood, Chicago]]",
    "founder": "Wallace Calvin Abbott",
    "hq_location": "Abbott Park, Illinois, U.S.",
    "area_served": "Worldwide",
    "key_people": "{{ubl|class|=|nowrap|[[Robert B. Ford]]|([[chairman]] & [[Chief Executive Officer|CEO]])|ref|{{cite news |url=https://www.forbes.com/sites/brucejapsen/2018/10/18/after-20-years-abbott-ceo-miles-white-has-his-successor-in-mind|title=After 20 Years, Abbott Labs CEO Miles White Has Successor in Mind |website=Forbes |last1=Japsen |first1=Bruce|access-date=10 September 2019|archive-date=2 February 2023 |archive-url=https://web.archive.org/web/20230202015718/https://www.forbes.com/sites/brucejapsen/2018/10/18/after-20-years-abbott-ceo-miles-white-has-his-successor-in-mind/|url-status=live}}|</ref>|Robert Funck|([[Vice president#In business|EVP]] & [[Chief financial officer|CFO]])}}",
    "products": "{{ubl|[[Medication|Pharmaceutical drugs]] |[[Generic drug]]s |[[Medical device]]s |Diagnostic [[assay]]s |[[Dietary supplements]] |[[Nutrition]]als}}",
    "revenue": "{{increase}} {{US$|41.9&nbsp;billion|link|=|yes}} (2024)",
    "operating_income": "{{increase}} US$6.82&nbsp;billion (2024)",
    "net_income": "{{increase}} US$13.4&nbsp;billion (2024)",
    "assets": "{{increase}} US$81.4&nbsp;billion (2024)",
    "equity": "{{increase}} US$47.9&nbsp;billion (2024)",
    "num_employees": "{{circa|114,000}} (2024)",
    "website": "{{URL|abbott.com}}"
}